Clinical Trials Directory

Trials / Completed

CompletedNCT04597502

The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties

"The Effects of Synastol TC (Standardized Terminalia Chebula Fruit Extract) on the Gut Microbiome and Skin Biophysical Properties"

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Integrative Skin Science and Research · Industry
Sex
Female
Age
25 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the use of oral Terminalia chebula fruit extract on the gut microbiome and skin biophysical properties. The fruit is commonly used for skin treatments in India. It is thought to have antioxidant properties, reduce inflammation and affect the microorganisms in the gut. The information the investigators will learn from this study may indicate how and if oral dosing can affect the skin and gut microbiome. This may lead to an improved understanding of the skin and determine whether these oral products are effective for improving the skin's appearance.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTerminalia Chebula fruit extractOral TC fruit extract supplement taken by mouth twice per day
DIETARY_SUPPLEMENTPlaceboOral placebo taken by mouth twice per day
OTHERTopical Terminalia ChebulaApplied to both forearms and dorsal hands
OTHERTopical PlaceboApplied to both forearms and dorsal hands

Timeline

Start date
2020-10-15
Primary completion
2022-03-29
Completion
2022-09-01
First posted
2020-10-22
Last updated
2022-11-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04597502. Inclusion in this directory is not an endorsement.